QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
QQQ   416.98 (-1.52%)
AAPL   165.14 (-1.14%)
MSFT   399.25 (-1.24%)
META   484.04 (-3.54%)
GOOGL   153.51 (-1.60%)
AMZN   174.66 (-2.54%)
TSLA   148.73 (-0.80%)
NVDA   810.37 (-4.29%)
AMD   148.41 (-4.30%)
NIO   3.84 (-4.00%)
BABA   68.67 (-0.30%)
T   16.39 (+0.37%)
F   12.12 (+0.50%)
MU   107.68 (-3.80%)
GE   149.08 (-2.52%)
CGC   8.13 (+3.83%)
DIS   112.03 (-0.36%)
AMC   3.29 (+12.67%)
PFE   25.81 (+1.65%)
PYPL   62.14 (+0.06%)
XOM   120.16 (+1.38%)
Free Trial

Meridian Bioscience (VIVO) ESG Score & Sustainability Data

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free VIVO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Sustainability
Stock Analysis

Key ESG Takeaways for Meridian Bioscience

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of Meridian Bioscience. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Meridian Bioscience seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is mostly driven by its Antibodies, Diagnostic test kits, and Biochemical assay kits products.
  • Meridian Bioscience uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category seems to be driven mostly by its Laboratory reagents, Antibodies, and Diagnostic test kits products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Biochemical assay kits business, Meridian Bioscience would improve its net impact ratio by 2 percentage points.

VIVO Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+59.9%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+66.9%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+51.0%
Society First
Value set that emphasizes society impacts over other impacts.
+16.2%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+76.6%
Health First
Value set that emphasizes health impacts over other impacts.
+81.2%

Meridian Bioscience ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.34
+1.34
+1.65
+1.65
+0.03
+0.03
-0.02
-0.02
+0.00
-0.10
-0.10
+0.00
0.00
+0.00
+1.19
+1.19
-0.00
0.00
+0.00
-1.03
-1.03
-0.35
+3.46
+3.80
-0.02
+0.28
+0.30
+0.00
+0.00
-0.00
+0.06
+0.06
-0.01
+0.17
+0.18
-0.81
-0.80
+0.01
-0.36
-0.35
+0.01
-0.20
-0.20
+0.00
-0.17
-0.17
+0.00
-0.38
-0.37
+0.01

Upright Model Version 1.4.0
ESG Data Last Updated: March 20, 2024

Ad DTI
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

Meridian Bioscience ESG Score - Frequently Asked Questions

How is Meridian Bioscience doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Meridian Bioscience has a net impact ratio of 59.9%, indicating an overall positive sustainability impact. Meridian Bioscience seems to create the most significant positive value in the categories of Physical diseases, Taxes, and Jobs. Meridian Bioscience uses resources or causes negative impacts mostly in the categories of Scarce human capital, GHG emissions, and Waste. Learn more on the sustainability of Meridian Bioscience.


More ESG Stocks and Research Tools

Related Companies:
Stock Lists:
Sustainability Tools:
This page (NASDAQ:VIVO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends